Locally acting ACE-083 increases muscle volume in healthy volunteers

Activin A more prominently regulates muscle mass in primates than does GDF8

(2017) Esther Latres et al.   Nature Communications

Biochemistry and Biology of GDF11 and MyostatinResponse to Walker et al

(2016) Ryan G. Walker et al.   CIRCULATION RESEARCH

MRI biomarker assessment of neuromuscular disease progression: a prospective observational cohort study

(2016) Jasper M Morrow et al.   LANCET NEUROLOGY

Myostatin inhibitor ACE-031 treatment of ambulatory boys with Duchenne muscular dystrophy: Results of a randomized, placebo-controlled clinical trial

(2016) Craig Campbell et al.   MUSCLE & NERVE

Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial

(2015) Clemens Becker et al.   Lancet Diabetes & Endocrinology

Treatment of sporadic inclusion body myositis with bimagrumab

(2014) A. A. Amato et al.   NEUROLOGY

G.P.205

(2014) A. Mulivor et al.   NEUROMUSCULAR DISORDERS

Distinct Disease Phases in Muscles of Facioscapulohumeral Dystrophy Patients Identified by MR Detected Fat Infiltration

(2014) Barbara H. Janssen et al.   PLoS One

Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease

(2009) Louise R. Rodino-Klapac et al.   MUSCLE & NERVE

A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy

(2008) Kathryn R. Wagner et al.   ANNALS OF NEUROLOGY